According to the Santa Monica Observer, on August 1st the Drug Enforcement Administration (DEA) will reschedule cannabis from a schedule 1 controlled substance, to a schedule 2 controlled substance, allowing it to be used and researched for medical purposes.
According to the Observer, a DEA attorney who wishes to remain anonymous made it clear that the agency, on August 1st, plans to remove cannabis as a schedule 1 drug – which indicates that it has no known medical value – and place it as a schedule 2 drug, allowing it to be used for medical purposes (other schedule 2 drugs include cocaine and Oxycontin). Continue reading “DEA Attorney: Cannabis to be Rescheduled on August 1st”

